Cameroon vs Ghana: Previously treated cases tested for RR-/MDR-TB
Cameroon
100.0%
in 2024
Ghana
100.0%
in 2024
Cameroon rank
1st
Ghana rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Cameroon
- Ghana
How they compare
Cameroon currently reports 100.0% against 100.0% in Ghana, a difference of 0.0%.
The two have swapped places 1 time across 14 shared years of data; in 2010 it was Cameroon ahead.
Cameroon ranks 1st and Ghana ranks 1st of 180 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Ghana | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.8% | 75.0% | 22.2% | Ghana |
| 2020s | 97.2% | 98.6% | 1.4% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cameroon or Ghana?
- Cameroon, at 100.0% against 100.0% in Ghana as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cameroon and Ghana?
- 0.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Ghana?
- 14 years are reported by both, from 2010 to 2024.
- How do Cameroon and Ghana rank globally for previously treated cases tested for rr-/mdr-tb?
- Cameroon ranks 1st and Ghana ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.